Ofer Markman, PhD

Ofer Markman, PhD – Advisor to LPBI Group’s Founder on the Biotech Ecosystem in Israel

Roles at LPBI: UPDATED on 8/15/2020

Science: AI in healthcare, AI in medical diagnosis, BioIT Bioinformatics, Biomarkers and medical diagnostics, Glycobiology, Cancer and current Therapeutics, Microbiome, Clinical diagnostics, Diagnostic immunology

Business:

Biotech venture creation
Joint Venture 2.0 LPBI Group (30%) with ABI-Lab (70%)

Business Development responsibilities @LPBI: Biotech in Israel, in Switzerland and in other countries in Europe

Plan for Business Development Activity at 1.0 LPBI 4Q 2020

TNS #1: TEXT Analysis on our CONTENTS: NLP, ML, AI – INSIGHTS MEAN VALUE and Up-selling content = NEW WARES to be brought to the market

Phase 1: Natural Language Processing(NLP) – 24 months FREE Microsoft AZURE for Health
- Text Analysis done in parallel on three LPBI’s Article Collections building a Proof of Concept performed byLPBI Group’s 2020/2021 Academic Internship in Medical Text Analysis (MTA) with Natural Language Processing (MTA-NLP): 9/2020 – 9/2021 – Academic INTERNSHIPS in LIFE SCIENCES, Medicine, Biological Sciences, Drug Discovery
- Inputs for Proof of Concept are the following three:
(1) Top 12 articles by views (all domains)

(2) Sixteen Cancer Articles representing 8 topics in Cancer Volume 1

(3) Sixteen Genomics Articles representing 21 chapters in Genomics Volume 1

Roles on 2.0 LPBI Group’s TNS #1,2,3,4,5,6 https://pharmaceuticalintelligence.com/vision/

TNS #1: See above

TNS #2: EXEMPT due to conflict of interests

TNS #3: Podcasts – will not be a Money maker – will be a Reputation Builder – very important in Pharmaceutical MEDIA

TNS #4: Conversion e-Books to Audio and Articles to SoundCloud Audio files – Text to Audio [SEE New Yorker] – HAS POTENTIAL

TNS #5: Joint venture with Dr. Nir for Drug Discovery

TNS #6: e-Books Translations into Japanese, Spanish, Russian

Plan for Business Development Activity at 2.0 LPBI 1Q 2021

PENDING

On record:

Biotech Ecosystem in Israel – Introductions: Aviva and Biotech CEOs
DayOne Basel – https://www.dayone.swiss/dayone.html – The Swiss Innovation Hub for Precision Medicine – Introductions of LPBI Group
2Q 2020 Ofer will bring to LPBI Group’s new prospects for the Exit

Domains of Expertise

AI in healthcare
AI in medical diagnosis
BioIT Bioinformatics
Biomarkers and medical diagnostics
Glycobiology
Biotech venture creation
Cancer and current Therapeutics
Microbiome
Clinical diagnostics
Diagnostic immunology

oferm2015@gmail.com

+972-523-275720

Haifa, Israel

BIO

Dr. Markman is a serial entrepreneur with over 20 years of experience serving as CEO or CXO for several companies in the biotechnology, technology, and food technology space. He has raised over $70M in venture capital financing for companies that have had various successful exits, including some companies that remain private and others that have had an IPO. Most notably he was a founding partner of Procognia that has raised over $50M in 2007.

Dr Markman was a lecturer of Glycotechnology at the Ort Braude Engineering College and is leading a Science internship program reaching its 80 interns in 3 years land-mark goal

Ofer Published articles and invented multiple patents, Products he has led to markets were sold at over 8 digit dollars of revenue worldwide. As a leader in acceleration plans Dr Markman assisted dozens of entrepreneurs and young companies reach their business goals.

Dr. Markman holds a PhD in Chemistry from Boston College, and worked with Nobel Laureate Ada Yonath for his Master’s Degree.

Published 10 journal articles
Inventor in 14 granted patents
Major (res.) in Military Intelligence and HLS
2x Entrepreneur, raised $30M for two companies founded.

Experience

June 2014 – Present

Hub Manager, Global Medical Centers of Excellence (GMCE), Haifa Life Sciences Hub Innovation

Managing the Israeli branch of Global Medical Centers of Excellence, a US-based innovation facility that initiates and operates medical centers worldwide, including the Caribbean, Jamaica, Dubai and Ethiopia. Our center escorts start-up companies from seed stage to spin-off and new markets entry in all business aspects including market research, strategic consulting, business modeling and business planning.
Developed and executed a strong internship program with so far over 50 interns and over 15 companies that outsourced the internship to us. Over 40 high quality projects submitted.
Three Letters of Intent (LOI) received from top investors to build hospitals.
Developed and executed a top strategy workshop so far with over 10 clients, including companies from France and the Caribbean Islands.
Developed a network of investors reviewing investment opportunities in Israel, the Caribbean Islands, Canada and Europe.
Developed and ran a Technology Competition for technology in the aid of senior citizens (3^rd Age)
Ran one Hakathon (Arkathon IL 2019) https://gmce-inc.wixsite.com/gmce-haifa-hub/post/2019-arkathon

November 2016 – Present ASPARNA LTD EVP of Business Development

Joined Asparna at the request of its founder to lead the business pivot of Asparna from Research and B2C to Commercialization and B2B.
Responsible for business development activities including business modeling and funding
Participated in the entire business pivot strategic planning cycle with Asparna’s Founder, Mr. Laron.
Responsible for oversight and PMO execution of all customer-facing projects,
External relations include upcoming projects with the Ministry of Health, Israeli Post company, Matrix Israel and others.
Elected as member of the Board of Directors in recognition for accomplishments on behalf of Asparna

December 2014 – September 2016 Olive Grove Ventures Partner, CTO

Olive Grove Ventures (OGV) is a growth engine that cultivates successful sustainable businesses from Israeli innovation.
OGV develops and manages platforms that bridge the Israeli technology – U.S. market gap.
Was instrumental in co-founding MilkPro, a data-mining technology company combining dairy, food, environmental and social aspects of the Whey industry.
Initiated with other players a collaboration between Tel Chai College and Rutgers University Food Innovation Center.

September 2006 – September 2016 Ort Braude Biotechnology Faculty

Lectured for 10 years on Glyco-Technology at Ort Braude College.
Developed courses curriculum for several courses
Mentored students in credited internship and entrepreneurial projects

2000 – 2007 ProCognia Ltd Founder, CSO

ProCognia is a Biotechnology Company, providing analytical services to biopharmaceutical and biosimilars companies.

Co-founder of ProCognia,
Managed the Science Operations and new technology development and fund raised over $25M for bio-informatics in several rounds.
Assisted our customers in directing their products towards optimal glycosylation, for improved efficacy and safety.
For Biosimilars manufacturers, our services directed clone and cell line selection and manufacturing conditions towards a product with glycosylation profiles similar to the original product, as required by the regulatory authorities.